-
First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
Sonek J, Cicero S, Nicolaides K.
Am J Obstet Gynecol 2007;196:19. -
Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
Am J Obstet Gynecol 2006;194:397-401. -
Can aneroid sphygmomanometers be used at altitude?
Kametas NA, McAuliffe F, Krampl E, Nicolaides KH, Shennan AH.
J Hum Hypertens 2006;20:517-22. -
Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides KH.
Prenat Diagn 2005;25:977-83. -
Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
Nicolaides KH.
Am J Obstet Gynecol 2004;191:45-67. -
Sonographic markers of fetal aneuploidy: a review.
Cicero S, Sacchini C, Rembouskos G, Nicolaides KH.
Placenta 2003;24:S88-98. -
Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH.
Prenat Diagn 2003;23:306-10. -
Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
Cicero S, Longo D, Rembouskos G, Sacchini C, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:31-5. -
Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:400-2. -
Osteogenesis imperfecta and other skeletal dysplasias presenting with increased nuchal translucency in the first trimester.
Makrydimas G, Souka A, Skentou H, Lolis D, Nicolaides K.
Am J Med Genet 2001;98:117-20. -
Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study.
Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K.
Lancet 2001;358:1665-7. -
The 11-14 week scan.
Nicolaides KH, Heath V, Liao AW.
Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:581-94. -
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:307-10. -
The umbilical artery pulsatility index in the first trimester: is there an association with increased nuchal translucency or chromosomal abnormality?
Brown R, Di Luzio L, Gomes C, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:244-7. -
Early prenatal diagnosis of triploidy.
Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH.
Am J Obstet Gynecol 1997;176:550-4. -
Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness.
Jauniaux E, Gavrill P, Kuhn P, Kurdi W, Hyett J, Nicolaides KH.
Hum Reprod 1996;11:435-9. -
Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation: arterial, intracardiac and venous blood flow velocity studies.
Hecher K, Campbell S, Doyle P, Harrington K, Nicolaides KH.
Circulation 1995;91:129-38.